论文信息 - Phase II study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukemia. - 字舞流文

Phase II study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukemia.

K. Alimoghaddam | A. Ghavamzadeh | M. Jalili | S. Mousavi | B. Bahar | M. Iravani | S. Ghaffari | M. Jahani | S. Rostami